`
`UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF VIRGINIA
`ALEXANDRIA DIVISION
`
`
`
`RAI STRATEGIC HOLDINGS, INC. and
`R.J. REYNOLDS VAPOR COMPANY,
`
`
`Plaintiffs and Counterclaim
`Defendants,
`
`v.
`
`
`
`
`ALTRIA CLIENT SERVICES LLC; PHILIP
`MORRIS USA INC.; and PHILIP MORRIS
`PRODUCTS S.A.
`
`Defendants and Counterclaim
`Plaintiffs.
`
`Civil Action No. 1:20-cv-393-LO-TCB
`
`
`
`[PROPOSED] ORDER GRANTING PMI/ALTRIA’S OMNIBUS MOTION IN LIMINE
`
`Upon consideration of Plaintiffs Altria Client Services, LLC, Philip Morris USA Inc., and
`
`Philip Morris Products S.A.’s (collectively, “PMI/Altria”) Omnibus Motion in Limine (“Motion”)
`
`it is hereby:
`
`ORDERED, that PMI/Altria’s Motion is GRANTED,
`
`and FURTHER ORDERED, that Defendants RAI Strategic Holdings, Inc. and R.J.
`
`Reynolds Vapor Company (“RJR”) shall be precluded from, offering, or soliciting argument,
`
`evidence, and testimony regarding the following subjects at trial:
`
`1.
`
`
`2.
`
`3.
`
`
`4.
`
`Preclude RJR from relying on non-comparable agreements to suggest the amount
`of a reasonable royalty.
`
`Preclude RJR from violating its stipulation regarding prior art.
`
`No argument, evidence, or testimony about prior art invalidity not disclosed in
`expert reports.
`
`No reference to practicing the prior art as an alleged non-infringement defense.
`
`
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 883-1 Filed 01/21/22 Page 2 of 3 PageID# 23584
`
`
`5.
`
`
`6.
`
`
`7.
`
`
`8.
`
`9.
`
`10.
`
`11.
`
`
`12.
`
`13.
`
`14.
`
`Preclude RJR’s experts from relying on hearsay conversations with undisclosed
`third-parties and evidence produced in violation of the Court’s discovery order.
`
`Preclude RJR from arguing that it lacks control over suppliers of the accused
`products.
`
`Preclude lay opinion testimony from RJR’s fact witnesses about alleged non-
`infringement or invalidity.
`
`No reference to RJR’s patent infringement claims.
`
`No argument, evidence, or testimony about the pending ITC investigation or
`investigations involving Altria’s investment in third-party Juul.
`
`No reference to withdrawn claims or defenses.
`
`No reference to PMI/Altria’s decision not to sue third parties for infringing the
`asserted patents.
`
`No reference to RJR or Nu Mark’s Marking with third-party Fontem patent
`numbers.
`
`Preclude RJR from referencing the absence of Charles Higgins at trial.
`
`No argument, evidence, or testimony challenging FDA’s PMT and MRTP
`authorizations for IQOS.
`
`
`
`ENTERED this ____ day of __________, 2022.
`
`Alexandria, Virginia
`
`__________________________________
`
`
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 883-1 Filed 01/21/22 Page 3 of 3 PageID# 23585
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on this 21st day of January, 2022, a true and correct copy of the
`
`foregoing was served using the Court’s CM/ECF system, with electronic notification of such filing
`
`to all counsel of record:
`
`
`
`
`
`
`
`/s/ Maximilian A. Grant
`Maximilian A. Grant (VSB No. 91792)
`LATHAM & WATKINS LLP
`555 Eleventh Street, N.W., Suite 1000
`Washington, DC 20004
`Telephone: (202) 637-2200
`Facsimile: (202) 637-2201
`Email: max.grant@lw.com
`
`
`Counsel for Plaintiffs Altria Client Services
`LLC, Philip Morris USA Inc., and Philip
`Morris Products S.A.
`
`
`
`
`
`3
`
`